Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.39 |
| ▸ | RET | P07949 | 7/20 | 0.37 |
| ▸ | ROS1 | P08922 | 7/20 | 0.37 |
| ▸ | FLT3 | P36888 | 7/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.34 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL395555 | 1.00 | PIK3CA (0.39) | PIK3CARETROS1FLT3KCNH2 | |
| SCHEMBL394570 | 0.93 | CHRM4 (0.36) | PIK3CARETROS1FLT3KCNH2 | |
| SCHEMBL394569 | 0.93 | CHRM4 (0.36) | PIK3CARETROS1FLT3KCNH2 | |
| SCHEMBL1984281 | 0.86 | CHUK (0.40) | RETROS1FLT3ALDH1A1GAA | |
| SCHEMBL1984275 | 0.86 | CHUK (0.40) | RETROS1FLT3ALDH1A1GAA | |
| SCHEMBL1984278 | 0.86 | CHUK (0.40) | RETROS1FLT3ALDH1A1GAA | |
| SCHEMBL8202941 | 0.86 | CHUK (0.40) | RETROS1FLT3ALDH1A1GAA | |
| SCHEMBL10043016 | 0.85 | PDE4B (0.37) | PIK3CAFLT3KCNH2CHRM4AXL | |
| SCHEMBL1984570 | 0.83 | MAPK8 (0.40) | PIK3CAALDH1A1MAPK3 | |
| SCHEMBL1984569 | 0.83 | MAPK8 (0.40) | PIK3CAALDH1A1MAPK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101622-B2 | Pyridopyrimidinone inhibitors of PI3Kα and mTOR | EXELIXIS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| EP-2350070-A1 | PYRIDOPYRIMIDINONE INHIBITORS OF PI3K AND MTOR | Exelixis, Inc. (US) | 2011-08-03 | — | — | EP | disclosed |
| US-20100087456-A1 | PYRIDOPYRIMIDINONE INHIBITORS OF PI3K-ALPHA and mTOR | EXELIXIS, INC. (US) | 2010-04-08 | — | — | US | disclosed |
| WO-2010039740-A1 | PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα AND MTOR | EXELIXIS, INC. (US) | 2010-04-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087456-A1 | PYRIDOPYRIMIDINONE INHIBITORS OF PI3K-ALPHA and mTOR | PIK3CD, PIK3CA, MTOR | PIK3CA 2/4885RET 576/4885ROS1 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.